ADXS-HPV to be added to chemotherapy and radiotherapy in phase II/III anal cancer trial April 10, 2015
New trial evaluates farletuzumab in patients with platinum-sensitive ovarian cancer and low CA125 April 1, 2015
Apceth begins phase II trial of engineered cell therapy to treat gastrointestinal cancer March 30, 2015
RSS